Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Meihua International Medical Technologies | MHUA | Oct 31, 2024 | 0.68 | -1.79 |
MeiraGTx Holdings | MGTX | Oct 31, 2024 | 5.54 | -5.78 |
Meiwu Technology | WNW | Oct 31, 2024 | 0.77 | -2.52 |
Melar Acquisition I | MACI | Oct 31, 2024 | 10.04 | +0.20 |
Melar Acquisition I | MACIU | Oct 31, 2024 | 10.13 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Oct 31, 2024 | 6.72 | -1.90 |
MercadoLibre | MELI | Oct 31, 2024 | 2 037.18 | +0.81 |
Mercantile Bank | MBWM | Oct 31, 2024 | 42.86 | -2.50 |
Mercer International | MERC | Oct 31, 2024 | 6.52 | +1.09 |
Merchants Bancorp | MBIN | Oct 31, 2024 | 36.94 | +2.73 |
Merchants Bancorp B | MBINO | Oct 31, 2024 | 25.22 | +0.48 |
Merchants Bancorp C Pref | MBINN | Oct 31, 2024 | 23.00 | +1.79 |
Merchants Bancorp Pref D | MBINM | Oct 31, 2024 | 25.75 | -0.16 |
Merck & Co | MRK | Oct 31, 2024 | 102.32 | -2.39 |
Mercurity Fintech | MFH | Oct 31, 2024 | 1.13 | -8.87 |
Mercury General | MCY | Oct 31, 2024 | 67.63 | -5.89 |
Mercury Systems | MRCY | Oct 31, 2024 | 32.35 | -3.06 |
Mereo BioPharma ADR | MREO | Oct 31, 2024 | 4.21 | -0.94 |
Meridian | MRBK | Oct 31, 2024 | 14.04 | -0.43 |
MeridianLink | MLNK | Oct 31, 2024 | 21.96 | -1.83 |
Merit Medical Systems | MMSI | Oct 31, 2024 | 98.66 | +3.96 |
Meritage Homes | MTH | Oct 31, 2024 | 181.20 | +2.06 |
Merrill Lynch & Co. | IPB | Oct 31, 2024 | 26.50 | +2.59 |
Mersana Therapeutics | MRSN | Oct 31, 2024 | 1.81 | -3.21 |
Merus N.V | MRUS | Oct 31, 2024 | 49.93 | -2.63 |
Mesa Air Group | MESA | Oct 31, 2024 | 0.92 | +0.54 |
Mesa Laboratories | MLAB | Oct 31, 2024 | 114.04 | -0.82 |
Mesa Royalty Trust | MTR | Oct 31, 2024 | 6.13 | +0.33 |
Mesabi Royalty Trust | MSB | Oct 31, 2024 | 24.12 | +1.22 |
Mesoblast ADR | MESO | Oct 31, 2024 | 8.38 | -4.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.